ARCHIVES

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

This article is from The Cancer Letter archive.

Vol. 07 No. 23 | June 5, 1981

Download PDF Visit The Full Archive

Related Articles

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

Cancer Letter Accepts “Substantial” Settlement In New Copyright Claim

August 5, 1988

Gallo To Give Scripps Symposium’s Schwartz Lecture

August 9, 1985

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005